Don’t miss it! Fantastic presentations from Christine Desmedt Tari King MD Jason A. Mouabbi MD . I will be co-moderating with Siobhán Freeney Advocate #BreastDensity #LobularBC - thanks #sabcs2023 to include #patientadvocates #Globmob

ILC at #SABCS23 ‼️ ▪️Heterogeneity in diagnosis ▪️Unique genomic landscape and TME ▪️endocrine resistance ▪️More research is needed Moving towards specific/targeted therapies in ILC??

#SABCS23 - Lobular Breast Cancer LBC is unique in regards to its genomic landscape, resistance, dormancy & higher rates of disease-free recurrence & inferior overall survival. A great set of talks highlighting challenges & important research in this subpopulation #breastcancer

Great review of lobular breast cancer management - worth watching if you missed it! *Strong association w/hormone exposure *Worse outcomes luminal IDC vs ILC *More benefit with AI vs tamoxifen in postmenopausal Tari King MD @BWHSurgery Dana-Farber’s Breast Oncology Center Lobular Breast Cancer Alliance #SABCS23 #bcsm

As the speaker Jason A. Mouabbi MD stated himself - an ‘exciting’ talk on novel insights into lobular breast cancer through the lens of a medical oncologist. Dr. Steffi Oesterreich UPMC Hillman Cancer Center

Master class on clinical considerations in lobular neoplasia by Tari King MD Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center #SABCS23

Innovative approaches to ILC *90% express AR *>90% peritoneal mets on autopsy *improved radiotracers for PET *5% HER2 mutation *Multiple options for targeted therapy *May be role for immunotherapy & angiogenesis inhibitors Jason A. Mouabbi MD MD Anderson Cancer Center #SABCS23 #bcsm Lobular Breast Cancer Alliance

The Lobular Breast Cancer Session today at #SABCS23 moderated by Dr Steffi Oesterreich Dr. Steffi Oesterreich with Dr Jason Mouabbi Jason A. Mouabbi MD Dr Christine Desmedt Christine Desmedt Dr Tari King Tari King MD and Siobhán Freeney Siobhán Freeney Advocate #BreastDensity #LobularBC Lobular Breast Cancer IRL #LivingWithLobular ELBCC

Grateful for the opportunity to present at #SABCS23! Huge thanks to the organizing committee for the invitation. I’m optimistic about the future of ILC management and hope my presentation conveyed the promise ahead. 🙏 #EndCancer MD Anderson Cancer Center Lobular Breast Cancer Alliance OncoAlert

Such a huge deal to see #lobular #breastcancer being added to the #SABCS23 lineup! #lobmob @lobularBCA LobularBCUK ELBCC

Dr. Jason Mouabbi discusses the challenges of treating lobular breast cancer with Dr. Kate Lathrop in this episode of SABCS Snippets, highlighting advances being presented at #SABCS23 to address these challenges. Watch now: youtu.be/5oW5JFQKipQ Jason A. Mouabbi MD AACR UT Health San Antonio MD Anderson

Come visit the Lobular Breast Cancer Alliance at #1615 #sabcs23 #bcsm #lobular #lobmob 🦞🦞🦞🦞

Are you at #SABCS23 this week? Be sure to stop by our booth (1615), meet us, and pick up some information to share about #lobular #breastcancer. laurie hutcheson Julia Katherine Amy McCart SABCS #bcsm Double Whammy

We are thrilled to see this interview with LBCA Scientific Advisory Board Chair Jason A. Mouabbi MD discussing #lobular #breastcancer at #SABCS23. Thanks, SABCS, for sharing more about ILC with your audience. #bcsm

Thursday night, 5-6pm at #SABCS2023 - stop by the GE HealthCare Med Affairs booth #215 and chat with #lobularcarcinoma specialist Jason A. Mouabbi MD of MD Anderson Cancer Center and Lobular Breast Cancer Alliance about improving methods for early detection and optimal staging.

LBCA is announcing another ILC grant solicitation for two ILC research grants of $50K each in partnership with the American Society for Clinical Oncology (ASCO) and two generous partners. More info here: society.asco.org/career-develop… read the RFP here: society.asco.org/sites/new-www.…

The new $5K sponsorship - the Lobular Breast Cancer Research Abstract Merit Award is announced in collaboration with @aacr_cancerresearch for the best abstracts on lobular breast cancer at SABCS. Read more here: lobularbreastcancer.org/announcing-the… #lobularbreastcancer #ilcresearch

LBCA’s latest 5-minute PSA addresses why breast cancer clinical trials are so crucial for finding treatments for all breast cancer types. Watch and share: lobularbreastcancer.org/lbca-releases-… #breastcancerresearch #breastcancerclinicaltrials #breastcancertreatments #breastcancerpsa

The LBCA Invasive Lobular Carcinoma Research Grant application deadline is extended to Sept. 23rd, details here: society.asco.org/career-develop…